No Result
View All Result
Success American Investors
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock
No Result
View All Result
Success American Investors
No Result
View All Result
Home Investing

Michelle Mone-linked PPE firm faces £122m high court battle with government

by
June 11, 2025
in Investing
0
Michelle Mone-linked PPE firm faces £122m high court battle with government
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

A high-stakes legal battle begins at the High Court today as the UK government seeks to recover £122 million from PPE Medpro, a company awarded Covid-era contracts following a recommendation from Conservative peer Michelle Mone.

The Department of Health and Social Care (DHSC) is suing PPE Medpro for the return of funds paid for 25 million sterile surgical gowns supplied in 2020, which were ultimately rejected as unsuitable for NHS use. The department is also claiming an additional £11 million to cover storage, disposal, and associated costs, as well as interest.

The case centres on two contracts worth more than £200 million awarded via the government’s now-infamous “VIP lane”—a fast-track procurement process that gave priority to companies with political connections during the pandemic. PPE Medpro was awarded a £122m gown contract and an £80.85m deal to supply face masks.

At the time, both Mone and her husband, Isle of Man financier Doug Barrowman, denied involvement in the company. However, a series of Guardian investigations later revealed that Mone had personally lobbied ministers, including then-Cabinet Office minister Michael Gove, and that Barrowman had received over £65 million in profits from the contracts.

In late 2023, Mone publicly admitted she had lied about her links to PPE Medpro, and Barrowman confirmed he had transferred £29 million into a trust benefiting Mone and her adult children.

While the supplied face masks were accepted and used, the surgical gowns were never deployed. According to the DHSC’s legal filings, the gowns were “non-sterile”, carried “invalid technical labelling”, and posed a risk to patient safety. The government maintains they were “not fit for any purpose within the NHS”.

PPE Medpro continues to deny wrongdoing. In a statement this week, the company said it “categorically denies breaching its obligations” and pledged to “robustly defend” its position in court.

The High Court case is separate from an ongoing criminal investigation by the National Crime Agency (NCA) into the procurement process and the couple’s financial dealings. In April 2022, the NCA raided several properties linked to the pair. Earlier this year, the Crown Prosecution Service secured a court order to freeze £75 million of their assets—an application Mone and Barrowman did not contest. Both deny any criminal wrongdoing.

The case is expected to intensify scrutiny over the government’s use of the pandemic procurement “VIP lane”, which has faced widespread criticism for lack of transparency and due diligence. It also raises questions about the role of peers and politically connected figures in lobbying for lucrative public contracts.

PPE Medpro’s legal team is set to argue that the gowns were produced in China to the correct specifications and were sterile when shipped. The company has claimed its products “undoubtedly helped keep NHS workers safe” and insists the DHSC’s rejection of the gowns was unfounded.

The DHSC has declined to comment on the case while proceedings are ongoing. The trial is expected to last several weeks and could set a significant precedent for future government efforts to recover funds related to pandemic-era procurement.

Read more:
Michelle Mone-linked PPE firm faces £122m high court battle with government

Previous Post

Sizewell C secures £14.2bn state boost – but energy savings won’t come for a decade

Next Post

House of Lords AI summit at London Tech Week warns of ‘skills cliff edge’ threatening UK’s competitive future

Next Post
House of Lords AI summit at London Tech Week warns of ‘skills cliff edge’ threatening UK’s competitive future

House of Lords AI summit at London Tech Week warns of ‘skills cliff edge’ threatening UK’s competitive future

Get the daily email that makes reading the news actually enjoyable. Stay informed and entertained, for free.
Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!
  • Trending
  • Comments
  • Latest
Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

Vertica: The new Israeli start-up challenger to Viagra proving ‘life-changing’ for men with ED

February 14, 2024

Last Day to Give in 2023!

December 31, 2023
Idaho Bucks Managed Care Trend

Idaho Bucks Managed Care Trend

December 5, 2023

The Producer Price Index

September 9, 2023

Trump Can, and Must, Avoid War with Iran

0

0

0

0

Trump Can, and Must, Avoid War with Iran

June 12, 2025

Participate in the virtual release of a report on the lifestyle in Carlisle

June 12, 2025

Are WNBA Players Underpaid or Overpaid?

June 12, 2025
EDF buys EV charger firm pod point for just £10m – four years after £352m london float

EDF buys EV charger firm pod point for just £10m – four years after £352m london float

June 12, 2025

Recent News

Trump Can, and Must, Avoid War with Iran

June 12, 2025

Participate in the virtual release of a report on the lifestyle in Carlisle

June 12, 2025

Are WNBA Players Underpaid or Overpaid?

June 12, 2025
EDF buys EV charger firm pod point for just £10m – four years after £352m london float

EDF buys EV charger firm pod point for just £10m – four years after £352m london float

June 12, 2025

Disclaimer: SuccessAmericanInvestors.com, its managers, its employees, and assigns (collectively "The Company") do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

  • About us
  • Contact us
  • Privacy Policy
  • Terms & Conditions

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.

No Result
View All Result
  • News
  • Economy
  • Editor’s Pick
  • Investing
  • Stock

Copyright © 2025 SuccessAmericanInvestors. All Rights Reserved.